Last Updated : October 28, 2019
Today, CADTH has issued final recommendations for:
insulin degludec + liraglutide (Xultophy)
Indications: Diabetes mellitus, Type 2
Recommendation: Reimburse with clinical criteria and/or conditions
Last Updated : October 28, 2019